Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Seongsung Kwak"'
Autor:
Junhyung Kim, Seongsung Kwak, Mi-Sun Park, Chang-Hoon Rhee, Gi-Hyeok Yang, Jangmi Lee, Woo-Chan Son, Won-ho Kang
Publikováno v:
PLoS ONE, Vol 17, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/15ff99eb3ee6470eb0daaa6d44dc0900
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
In recent, Botulinum Neurotoxin A1 (BoNT/A1) has been suggested as a potential anticancer agent due to neuronal innervation in tumor cells. Although potential BoNT/A1’s mechanism of action for the tumor suppression has been gradually revealed so fa
Externí odkaz:
https://doaj.org/article/9467bb2e0cdf4fb2a5f399439996d781
Autor:
Jaeyoon Byun, Seongsung Kwak, Jin-Hee Kwon, Minhee Shin, Dong-Kyu Lee, Chang-Hoon Rhee, Won-ho Kang, Jae-Wook Oh, Deu John M. Cruz
Publikováno v:
Toxins, Vol 14, Iss 6, p 365 (2022)
Botulinum neurotoxin type A (BoNT/A) causes muscle paralysis by blocking cholinergic signaling at neuromuscular junctions and is widely used to temporarily correct spasticity-related disorders and deformities. The paralytic effects of BoNT/A are time
Externí odkaz:
https://doaj.org/article/6849d15faa984735a87d42f7a89aba46
Autor:
Junhyung Kim, Seongsung Kwak, Mi-Sun Park, Chang-Hoon Rhee, Gi-Hyeok Yang, Jangmi Lee, Woo-Chan Son, Won-Ho Kang
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256869 (2021)
Human serum albumin (HSA) has been widely used as a pharmaceutical excipient in Botulinum toxin serotype A (BoNT/A) products that are indicated for use in therapeutics and cosmetics. However, HSA as a human-derived material has some concerns, such as
Externí odkaz:
https://doaj.org/article/5567dfe9e40140f0bce4f59b3a844aa8
Autor:
Seongsung Kwak, Da Som Jeong, Mi-Sun Park, Min-Seo Choi, Chang-Hoon Rhee, Junhyung Kim, Won-ho Kang, Gi-Hyeok Yang, Tae-hee Kim, Woo-Chan Son, Soo Min Ko
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Min-Seo Choi,1,* Seongsung Kwak,1,2,* Junhyung Kim,1 Mi-Sun Park,1 Soo Min Ko,2 Taehee Kim,2 Da Som Jeong,2 Chang-Hoon Rhee,3 Gi-Hyeok Yang,1,3 Woo-Chan Son,2 Won-Ho Kang1 1Gwanggyo R&D Center, Medytox Inc, Suwon-si, Gyeonggi-do, Republic of
Publikováno v:
Pharmaceutics, Vol 13, Iss 133, p 133 (2021)
Pharmaceutics
Volume 13
Issue 2
Pharmaceutics
Volume 13
Issue 2
Dermal fillers are gel-type substances for nonsurgical medical-device use to achieve facial rejuvenation. Currently, the most widely used skin fillers are hyaluronic-acid-based dermal fillers. This study aimed to explain the change in the volume of i
Publikováno v:
Dermatologic Surgery; Dec2020, Vol. 46 Issue 12, pe132-e138, 7p